TP53 and breast cancer: BL1 breast cancers overexpress genes in the DNA damage response pathway and are stained by Ki67 while BL2 tumors are associated with the upregulation of growth factor signaling, TP53, and myoepithelial markers (Fragomeni et al. 2018; Pareja et al. 2016).